Action on neovascular age-related macular degeneration (nAMD): recommendations for management and service provision in the UK hospital eye service
出版年份 2019 全文链接
标题
Action on neovascular age-related macular degeneration (nAMD): recommendations for management and service provision in the UK hospital eye service
作者
关键词
-
出版物
EYE
Volume 33, Issue S1, Pages 1-21
出版商
Springer Science and Business Media LLC
发表日期
2019-03-30
DOI
10.1038/s41433-018-0300-3
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Implementation of medical retina virtual clinics in a tertiary eye care referral centre
- (2018) Karsten Kortuem et al. BRITISH JOURNAL OF OPHTHALMOLOGY
- Treat-and-Extend versus Monthly Regimen in Neovascular Age-Related Macular Degeneration
- (2018) Rufino Silva et al. OPHTHALMOLOGY
- Real-world outcomes in patients with neovascular age-related macular degeneration treated with intravitreal vascular endothelial growth factor inhibitors
- (2018) Hemal Mehta et al. PROGRESS IN RETINAL AND EYE RESEARCH
- VISUAL ACUITY IMPROVEMENT WHEN SWITCHING FROM RANIBIZUMAB TO AFLIBERCEPT IS NOT SUSTAINED
- (2018) Cecilia S. Lee et al. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
- Switching between ranibizumab and aflibercept for the treatment of neovascular age-related macular degeneration
- (2018) Irmela Mantel et al. SURVEY OF OPHTHALMOLOGY
- One-year real-world outcomes in patients receiving fixed-dosing aflibercept for neovascular age-related macular degeneration
- (2017) H Almuhtaseb et al. EYE
- Appropriateness of quality standards for meaningful intercentre comparisons of aflibercept service provision for neovascular age-related macular degeneration
- (2017) J S Talks et al. EYE
- A systematic review to assess the ‘treat-and-extend’ dosing regimen for neovascular age-related macular degeneration using ranibizumab
- (2017) S R Rufai et al. EYE
- Fundamental principles of an anti-VEGF treatment regimen: optimal application of intravitreal anti–vascular endothelial growth factor therapy of macular diseases
- (2017) Paolo Lanzetta et al. GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY
- Bilateral Neovascular Age-Related Macular Degeneration: Comparisons between First and Second Eyes
- (2017) Jamie K. Chew et al. OPHTHALMOLOGICA
- The Current State of Teleophthalmology in the United States
- (2017) Siddarth Rathi et al. OPHTHALMOLOGY
- Investigation of time to first presentation and extrahospital factors in the treatment of neovascular age-related macular degeneration: a retrospective cross-sectional study
- (2017) Peng Yong Sim et al. BMJ Open
- Evaluating Effects of Switching Anti–Vascular Endothelial Growth Factor Drugs for Age-Related Macular Degeneration and Diabetic Macular Edema
- (2017) Frederick L. Ferris et al. JAMA Ophthalmology
- Defining a Minimum Set of Standardized Patient-centered Outcome Measures for Macular Degeneration
- (2016) Ian A. Rodrigues et al. AMERICAN JOURNAL OF OPHTHALMOLOGY
- UK Neovascular Age-Related Macular Degeneration Database. Report 6: time to retreatment after a pause in therapy. Outcomes from 92 976 intravitreal ranibizumab injections
- (2016) Krishnappa C Madhusudhana et al. BRITISH JOURNAL OF OPHTHALMOLOGY
- Effects of switching from ranibizumab to aflibercept in eyes with exudative age-related macular degeneration
- (2016) Daniel Barthelmes et al. BRITISH JOURNAL OF OPHTHALMOLOGY
- The UK Neovascular AMD Database Report 3: inter-centre variation in visual acuity outcomes and establishing real-world measures of care
- (2016) G Liew et al. EYE
- Leading causes of certifiable visual loss in England and Wales during the year ending 31 March 2013
- (2016) A Quartilho et al. EYE
- A view of the current and future role of optical coherence tomography in the management of age-related macular degeneration
- (2016) U Schmidt-Erfurth et al. EYE
- Effectiveness of UK optometric enhanced eye care services: a realist review of the literature
- (2016) Helen Baker et al. OPHTHALMIC AND PHYSIOLOGICAL OPTICS
- Characteristics and Predictors of Early and Delayed Responders to Ranibizumab Treatment in Neovascular Age-Related Macular Degeneration: A Retrospective Analysis from the ANCHOR, MARINA, HARBOR, and CATT Trials
- (2016) Richard Gale et al. OPHTHALMOLOGICA
- Treatment Patterns and Visual Outcomes during the Maintenance Phase of Treat-and-Extend Therapy for Age-Related Macular Degeneration
- (2016) Rohan W. Essex et al. OPHTHALMOLOGY
- METAANALYSIS OF REAL-WORLD OUTCOMES OF INTRAVITREAL RANIBIZUMAB FOR THE TREATMENT OF NEOVASCULAR AGE-RELATED MACULAR DEGENERATION
- (2016) Leah N. Kim et al. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
- INTRAVITREAL AFLIBERCEPT FOR CHOROIDAL NEOVASCULARIZATION DUE TO AGE-RELATED MACULAR DEGENERATION UNRESPONSIVE TO RANIBIZUMAB THERAPY
- (2016) Valentina Sarao et al. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
- Effectiveness of Community versus Hospital Eye Service follow-up for patients with neovascular age-related macular degeneration with quiescent disease (ECHoES): a virtual non-inferiority trial
- (2016) Barnaby C Reeves et al. BMJ Open
- A Meta-Analysis of Studies Evaluating Visual and Anatomical Outcomes in Patients with Treatment Resistant Neovascular Age-Related Macular Degeneration following Switching to Treatment with Aflibercept
- (2016) Sophie Seguin-Greenstein et al. Journal of Ophthalmology
- The concept of virtual clinics in monitoring patients with age-related macular degeneration
- (2015) Konstantinos T. Tsaousis et al. ACTA OPHTHALMOLOGICA
- UK AMD EMR USERS GROUP REPORT V: benefits of initiating ranibizumab therapy for neovascular AMD in eyes with vision better than 6/12
- (2015) Aaron Y Lee et al. BRITISH JOURNAL OF OPHTHALMOLOGY
- Ranibizumab for the treatment of wet AMD: a summary of real-world studies
- (2015) V Chong EYE
- Long-term visual outcomes of intravitreal ranibizumab treatment for wet age-related macular degeneration and effect on blindness rates in south-east Scotland
- (2015) S Borooah et al. EYE
- Defining response to anti-VEGF therapies in neovascular AMD
- (2015) W M Amoaku et al. EYE
- Improving patient access to prevent sight loss: ophthalmic electronic referrals and communication (Scotland)
- (2015) A.A. Khan et al. PUBLIC HEALTH
- SUSTAINED ELEVATION OF INTRAOCULAR PRESSURE AFTER INTRAVITREAL ANTI-VEGF AGENTS
- (2015) Vaidehi S. Dedania et al. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
- Health professionals' and service users' perspectives of shared care for monitoring wet age-related macular degeneration: a qualitative study alongside the ECHoES trial
- (2015) D. Townsend et al. BMJ Open
- The cost-effectiveness of initiating ranibizumab therapy in eyes with neovascular AMD with good vision: an economic model using real-world outcomes
- (2015) T. Butt et al. BMJ Open
- Repeated Intravitreous Ranibizumab Injections for Diabetic Macular Edema and the Risk of Sustained Elevation of Intraocular Pressure or the Need for Ocular Hypotensive Treatment
- (2015) Susan B. Bressler et al. JAMA Ophthalmology
- Consequences of long-term discontinuation of vascular endothelial growth factor inhibitor therapy in the patients with neovascular age-related macular degeneration
- (2014) Anagha Vaze et al. ACTA OPHTHALMOLOGICA
- Guidelines for the management of neovascular age-related macular degeneration by the European Society of Retina Specialists (EURETINA)
- (2014) Ursula Schmidt-Erfurth et al. BRITISH JOURNAL OF OPHTHALMOLOGY
- Multi-country real-life experience of anti-vascular endothelial growth factor therapy for wet age-related macular degeneration
- (2014) Frank G Holz et al. BRITISH JOURNAL OF OPHTHALMOLOGY
- Diagnostic accuracy of the Amsler grid and the preferential hyperacuity perimetry in the screening of patients with age-related macular degeneration: systematic review and meta-analysis
- (2014) L Faes et al. EYE
- Utilisation of orthoptists to give intravitreal injections—a multidisciplinary approach
- (2014) S P Mall et al. EYE
- Short-term intraocular pressure trends following intravitreal ranibizumab injections for neovascular age-related macular degeneration—the role of oral acetazolamide in protecting glaucoma patients
- (2014) C D Murray et al. EYE
- Switch of anti-VEGF agents is an option for nonresponders in the treatment of AMD
- (2014) C Ehlken et al. EYE
- Implementation of a nurse-delivered intravitreal injection service
- (2014) J DaCosta et al. EYE
- The accuracy of home monitoring to detect disease activity during maintenance therapy for neovascular ARMD
- (2014) Martin McKibbin et al. GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY
- Rate of vision loss in neovascular age-related macular degeneration explored
- (2014) Juan P. Real et al. GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY
- The Neovascular Age-Related Macular Degeneration Database: Multicenter Study of 92 976 Ranibizumab Injections
- (2014) OPHTHALMOLOGY
- The Neovascular Age-Related Macular Degeneration Database
- (2014) Javier Zarranz-Ventura et al. OPHTHALMOLOGY
- Seven-Year Outcomes in Ranibizumab-Treated Patients in ANCHOR, MARINA, and HORIZON
- (2013) Soraya Rofagha et al. OPHTHALMOLOGY
- Time Trends in the Incidence and Causes of Blindness in Israel
- (2012) Alon Skaat et al. AMERICAN JOURNAL OF OPHTHALMOLOGY
- Incidence of Legal Blindness From Age-Related Macular Degeneration in Denmark: Year 2000 to 2010
- (2012) Sara Brandi Bloch et al. AMERICAN JOURNAL OF OPHTHALMOLOGY
- The estimated prevalence and incidence of late stage age related macular degeneration in the UK
- (2012) Christopher G Owen et al. BRITISH JOURNAL OF OPHTHALMOLOGY
- Which visual acuity measurements define high-quality care for patients with neovascular age-related macular degeneration treated with ranibizumab?
- (2012) A H Ross et al. EYE
- Visual impairment certification secondary to ARMD in Leeds, 2005–2010: is the incidence falling?
- (2012) E Rostron et al. EYE
- Combined OCT and colour fundus photography in virtual clinic assessments of wet AMD patients
- (2012) M Mookhtiar et al. EYE
- Action on AMD. Optimising patient management: act now to ensure current and continual delivery of best possible patient care
- (2012) W Amoaku et al. EYE
- Intravitreal Aflibercept (VEGF Trap-Eye) in Wet Age-related Macular Degeneration
- (2012) Jeffrey S. Heier et al. OPHTHALMOLOGY
- Ranibizumab and Bevacizumab for Neovascular Age-Related Macular Degeneration
- (2011) NEW ENGLAND JOURNAL OF MEDICINE
- Age-Related Macular Degeneration and Risk Factors for the Development of Choroidal Neovascularisation in the Fellow Eye: A 3-Year Follow-Up Study
- (2011) Rufino Silva et al. OPHTHALMOLOGICA
- Delay between medical indication to anti-VEGF treatment in age-related macular degeneration can result in a loss of visual acuity
- (2010) Philipp Sebastian Muether et al. GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now